William L. Current
Algemeen Adviseur bij Apexian Pharmaceuticals, Inc.
Profiel
William L.
Current is currently the Vice President-Regulatory Affairs at Apexian Pharmaceuticals, Inc. He previously worked as the Vice President-Regulatory Affairs at Targanta Therapeutics Corp.
Dr. Current holds a doctorate degree from the University of Nebraska, an undergraduate degree from New Mexico State University, and a graduate degree from Washington State University.
Actieve functies van William L. Current
| Bedrijven | Functie | Begin |
|---|---|---|
Apexian Pharmaceuticals, Inc.
 Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Algemeen Adviseur | 01-12-2014 |
Eerdere bekende functies van William L. Current
| Bedrijven | Functie | Einde |
|---|---|---|
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Algemeen Adviseur | - |
Opleiding van William L. Current
| New Mexico State University | Undergraduate Degree |
| Washington State University | Graduate Degree |
| University of Nebraska | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | Health Technology |
